Adult Growth Hormone Deficiency epidemiology analysis during the study period (2018-30) by DelveInsight

June 15 20:05 2021
Adult Growth Hormone Deficiency epidemiology analysis during the study period (2018-30) by DelveInsight

Adult Growth Hormone Deficiency Epidemiology Forecast
The ‘Adult Growth Hormone Deficiency (AGHD) – Epidemiology Forecast to 2030’ report from DelveInsight provides an in-depth understanding of the disease, historical and forecasted Adult Growth Hormone Deficiency (AGHD) epidemiology in the 7MM, namely the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

The Adult Growth Hormone Deficiency (AGHD) – Epidemiology Forecast to 2030′ report from DelveInsight provides an in-depth understanding of the disease, historical and forecasted Adult Growth Hormone Deficiency (AGHD) epidemiology in the 7MM, namely the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some Key Highlights from the Adult Growth Hormone Deficiency Epidemiology Report

  • According to Jana Bujanova et al., the prevalence of Adult Growth Hormone Deficiency in the UK is estimated to be 1 in 10,000.

  • According to estimates from the Growth Hormone Foundation, over 50,000 persons in the United States are growth hormone deficient, with 6,000 new instances recorded each year, including GHD children who transition to GHD as an adult.

  • According to Akira Shimatsu et al. study, Adult Onset GHD affects a higher percentage of Japanese adults (80%) than Childhood Onset GHD.

To know more, request sample @ Adult Growth Hormone Deficiency Epidemiology

Adult Growth Hormone Deficiency: Overview

Adult-Onset Growth Hormone Deficiency (AGHD) is a medical condition caused by a lack of growth hormone production in the body. It promotes the production of another hormone known as insulin-like growth factor 1, which is primarily produced by the liver. These hormones work together to promote growth in children and have wide-ranging metabolic impacts in adults.

Adults with GHD are divided into two groups: Childhood Onset (GHD that began in childhood and has since progressed) and Adult Onset (GHD developed after reaching adulthood).

Adult Growth Hormone Deficiency Epidemiology Segmentation

  • Adult Growth Hormone Deficiency Prevalent Cases

  • Childhood Onset GHD, Adult Onset GHD Diagnosed Prevalent Cases

  • Adult Growth Hormone Deficiency Gender-Specific Prevalent Cases

  • Adult Growth Hormone Deficiency Diagnosed and Treatable Cases

For more insights visit, Adult Growth Hormone Deficiency Treatment Approaches

Table of Contents 

1.

Key Insights

2.

Adult Growth Hormone Deficiency: Market Overview at a Glance

3.

Organisations

4.

Executive Summary

5.

Methodology

6.

Adult Growth Hormone Deficiency: Disease Background and Overview

7.

AGHD Epidemiology and Patient Population

8.

Total Prevalent Population of Adult Growth Hormone Deficiency in 7MM

9.

AGHD: United States Epidemiology

10.

AGHD: EU5 Epidemiology

11.

AGHD: Japan Epidemiology

12.

SWOT Analysis

13.

KOL Views

14.

Case studies

15.

Appendix

16.

DelveInsight Capabilities

17.

Disclaimer

18.

About DelveInsight

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare and Biotech Blog Posts

Related Reports

Adult Myopia Epidemiology Forecast

DelveInsight’s ‘Adult Myopia–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the historical and forecasted epidemiology Adult Myopia in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/